Yabing Du

411 total citations
23 papers, 268 citations indexed

About

Yabing Du is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yabing Du has authored 23 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Yabing Du's work include RNA modifications and cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune cells in cancer (4 papers). Yabing Du is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune cells in cancer (4 papers). Yabing Du collaborates with scholars based in China, United States and Germany. Yabing Du's co-authors include Kang Cui, Wang Ma, Luyan Shen, Ke‐Neng Chen, Shuiling Jin, Qingxia Fan, Huan Zhao, Feng Han, Junlin Yu and Yurong Du and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Biological Macromolecules.

In The Last Decade

Yabing Du

21 papers receiving 264 citations

Peers

Yabing Du
Zhuxian Zhu China
Kyle Dammann Austria
Xingwei Xu China
Ayyoob Khosravi Iran
Pui Yan Siak Malaysia
Mingmei Liao China
Vahid Niazi Iran
Shi-Ping Lu China
Yi-Fan Zhou China
Zhuxian Zhu China
Yabing Du
Citations per year, relative to Yabing Du Yabing Du (= 1×) peers Zhuxian Zhu

Countries citing papers authored by Yabing Du

Since Specialization
Citations

This map shows the geographic impact of Yabing Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yabing Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yabing Du more than expected).

Fields of papers citing papers by Yabing Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yabing Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yabing Du. The network helps show where Yabing Du may publish in the future.

Co-authorship network of co-authors of Yabing Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yabing Du. A scholar is included among the top collaborators of Yabing Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yabing Du. Yabing Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Zhenzhen, et al.. (2025). Photoimmunotherapy biomimetic nanoplatform for lung cancer and brain metastasis. Materials & Design. 257. 114497–114497.
2.
Wang, Kai, et al.. (2025). Theoretical exploration of the structural evolution and electronic properties of LiAl (n = 3–20) clusters. Computational and Theoretical Chemistry. 1250. 115292–115292. 5 indexed citations
3.
Wang, Kai, et al.. (2025). Determination of the ground state structures of anionic Ga (n = 2–15) clusters. Computational and Theoretical Chemistry. 1247. 115157–115157. 4 indexed citations
4.
Liu, Zhenkun, et al.. (2024). AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization. Journal for ImmunoTherapy of Cancer. 12(10). e009877–e009877. 9 indexed citations
5.
Du, Yurong, Lei Liu, Yang Li, et al.. (2023). The anticancer mechanisms of exopolysaccharide from Weissella cibaria D-2 on colorectal cancer via apoptosis induction. Scientific Reports. 13(1). 21117–21117. 10 indexed citations
6.
Wang, Huanrong, Lei Liu, Jiaqin Yan, et al.. (2023). Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse. Frontiers in Oncology. 12. 1097816–1097816. 4 indexed citations
7.
Liu, Lei, Yurong Du, Yabing Du, et al.. (2023). Exopolysaccharide from Weissella confusa J4-1 inhibits colorectal cancer via induction of cell cycle arrest. International Journal of Biological Macromolecules. 253(Pt 8). 127625–127625. 5 indexed citations
8.
9.
Du, Yurong, Lei Liu, Yabing Du, et al.. (2023). The role of extratumoral and intratumoral microorganisms in cancer immunotherapy. 1(2). 100016–100016. 11 indexed citations
10.
11.
Du, Yabing, Yikai Han, Xin Wang, et al.. (2022). Identification of Immune-Related Breast Cancer Chemotherapy Resistance Genes via Bioinformatics Approaches. Frontiers in Oncology. 12. 5 indexed citations
12.
Zhao, Huan, Yurong Du, Lei Liu, et al.. (2022). Oral nanozyme-engineered probiotics for the treatment of ulcerative colitis. Journal of Materials Chemistry B. 10(21). 4002–4011. 34 indexed citations
13.
Zhu, Li, Kang Cui, Yabing Du, et al.. (2021). B4GALNT2 Gene Promotes Proliferation, and Invasiveness and Migration Abilities of Model Triple Negative Breast Cancer (TNBC) Cells by Interacting With HLA-B Protein. Frontiers in Oncology. 11. 722828–722828. 6 indexed citations
14.
Du, Yabing, Wang Ma, Peihao Wen, et al.. (2021). Phthalates promote the invasion of hepatocellular carcinoma cells by enhancing the interaction between Pregnane X receptor and E26 transformation specific sequence 1. Pharmacological Research. 169. 105648–105648. 31 indexed citations
15.
Zhu, Li, Kang Cui, Yabing Du, et al.. (2021). A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells. PLoS ONE. 16(6). e0249174–e0249174. 11 indexed citations
16.
Guo, Jiacheng, Kang Cui, Yabing Du, et al.. (2020). Thymosin alpha-1 blocks the accumulation of myeloid suppressor cells in NSCLC by inhibiting VEGF production. Biomedicine & Pharmacotherapy. 131. 110740–110740. 9 indexed citations
17.
Du, Yabing, Ni Shi, Seiji Arai, et al.. (2019). Modularized Perturbation of Alternative Splicing Across Human Cancers. Frontiers in Genetics. 10. 246–246. 1 indexed citations
18.
Cui, Kang, Shuiling Jin, Yabing Du, et al.. (2019). Long noncoding RNA DIO3OS interacts with miR-122 to promote proliferation and invasion of pancreatic cancer cells through upregulating ALDOA. Cancer Cell International. 19(1). 36 indexed citations
19.
20.
Du, Yabing, Bin Dong, Luyan Shen, et al.. (2014). The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma. Journal of Surgical Research. 188(2). 442–450. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuxian Zhu Breakdown of academic impact, for papers by Kyle Dammann Breakdown of academic impact, for papers by Xingwei Xu Breakdown of academic impact, for papers by Ayyoob Khosravi Breakdown of academic impact, for papers by Pui Yan Siak Breakdown of academic impact, for papers by Mingmei Liao Breakdown of academic impact, for papers by Vahid Niazi Breakdown of academic impact, for papers by Shi-Ping Lu Breakdown of academic impact, for papers by Yi-Fan Zhou
Rankless by CCL
2026